Breast Implant-associated Anaplastic Large Cell Lymphoma (BIA-ALCL) Registry
The Lymphoma Academic Research Organisation
150 participants
Jun 7, 2017
OBSERVATIONAL
Conditions
Summary
Anaplastic large cell lymphoma associated with breast implants (BIA-ALCL) is a rare disease seen only in women with a breast implant. Because of the low incidence of this disease and the peculiar histological subtype, French authorities, in accordance with the recommendations of an expert group, recommended the implementation of a BIA-ALCL case registry, in connection with a national Multidisciplinary meeting (Réunion de Concertation Pluridisciplinaire nationale de recours- RCP). This registry is opened in France and in Belgium
Eligibility
Inclusion Criteria1
- Adult patients with an anaplastic large cell lymphoma associated with breast implants
Exclusion Criteria1
- \-
Interventions
Observational : no intervention
Locations(31)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04220970